Neurodegenerative disease: PDK1--a common therapeutic target for AD and prion disease?

Suppr

超能文献

作者信息

Wood Heather

出版信息

Nat Rev Neurol. 2013 Oct;9(10):543. doi: 10.1038/nrneurol.2013.193. Epub 2013 Sep 10.

DOI:10.1038/nrneurol.2013.193

PMID:24018477

Abstract

摘要

相似文献

Neurodegenerative disease: PDK1--a common therapeutic target for AD and prion disease?

Nat Rev Neurol. 2013 Oct;9(10):543. doi: 10.1038/nrneurol.2013.193. Epub 2013 Sep 10.

Alzheimer's and prion diseases: PDK1 at the crossroads.

Nat Med. 2013 Sep;19(9):1088-90. doi: 10.1038/nm.3332.

Neurodegenerative diseases: New kinase targets for Alzheimer's disease.

Nat Rev Drug Discov. 2013 Oct;12(10):739. doi: 10.1038/nrd4132.

PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Nat Med. 2013 Sep;19(9):1124-31. doi: 10.1038/nm.3302. Epub 2013 Aug 18.

[From prion diseases to Alzheimer's disease: a common therapeutic target, PDK1].

Med Sci (Paris). 2014 Feb;30(2):139-41. doi: 10.1051/medsci/20143002008. Epub 2014 Feb 24.

The sheddase ADAM10 is a potent modulator of prion disease.

Elife. 2015 Feb 5;4:e04260. doi: 10.7554/eLife.04260.

Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.

FEBS J. 2013 Sep;280(18):4338-47. doi: 10.1111/febs.12196. Epub 2013 Mar 13.

α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins.

Curr Alzheimer Res. 2012 Feb;9(2):140-56. doi: 10.2174/156720512799361646.

The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.).

Eur J Neurosci. 2010 Oct;32(8):1245. doi: 10.1111/j.1460-9568.2010.07461.x.

Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.

Brain Res. 2014 Jan 30;1545:35-44. doi: 10.1016/j.brainres.2013.12.005. Epub 2013 Dec 12.

引用本文的文献

Convergent and Divergent Mitochondrial Pathways as Causal Drivers and Therapeutic Targets in Neurological Disorders.

Curr Issues Mol Biol. 2025 Aug 8;47(8):636. doi: 10.3390/cimb47080636.

本文引用的文献

PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Nat Med. 2013 Sep;19(9):1124-31. doi: 10.1038/nm.3302. Epub 2013 Aug 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验